Dye Capital Cann Holdings, II - 16 Dec 2020 Form 4 Insider Report for Medicine Man Technologies, Inc. (SHWZ)

Role
10%+ Owner
Signature
/s/ Justin C. Dye
Issuer symbol
SHWZ
Transactions as of
16 Dec 2020
Net transactions value
+$21,350,000
Form type
4
Filing time
08 Jun 2021, 15:58:20 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SHWZ Series A Cumulative Convertible Preferred Stock Purchase $7,700,000 +7,700 $1000.00* 7,700 16 Dec 2020 Common Stock 6,416,667 $1.20 Direct F1, F2, F3
transaction SHWZ Series A Cumulative Convertible Preferred Stock Purchase $1,450,000 +1,450 +19% $1000.00* 9,150 18 Dec 2020 Common Stock 1,208,333 $1.20 Direct F1, F2, F3
transaction SHWZ Series A Cumulative Convertible Preferred Stock Purchase $1,300,000 +1,300 +14% $1000.00* 10,450 22 Dec 2020 Common Stock 1,083,333 $1.20 Direct F1, F2, F3
transaction SHWZ Series A Cumulative Convertible Preferred Stock Purchase $3,100,000 +3,100 +30% $1000.00* 13,550 03 Feb 2021 Common Stock 2,583,333 $1.20 Direct F1, F2, F3
transaction SHWZ Series A Cumulative Convertible Preferred Stock Purchase $1,300,000 +1,300 +9.6% $1000.00* 14,850 25 Feb 2021 Common Stock 1,083,333 $1.20 Direct F1, F2, F3
transaction SHWZ Series A Cumulative Convertible Preferred Stock Purchase $2,500,000 +2,500 +17% $1000.00* 17,350 02 Mar 2021 Common Stock 2,083,333 $1.20 Direct F1, F2, F3
transaction SHWZ Series A Cumulative Convertible Preferred Stock Purchase $4,000,000 +4,000 +23% $1000.00* 21,350 30 Mar 2021 Common Stock 3,333,333 $1.20 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to adjustment, as described in the Certificate of Designation.
F2 The shares of Series A Cumulative Convertible Preferred Stock (the "Series A Preferred Shares") are convertible into shares of the common stock (the "Common Shares") of Medicine Man Technologies, Inc. (the "Company") upon the events specified in the Company's Certificate of Designation of Series A Cumulative Convertible Preferred Stock (the "Certificate of Designation"). The Preferred stock is perpetual and therefore has no expiration date.
F3 Represents the number of Common Shares issuable upon conversion of the Series A Preferred Shares on the date of the reported transaction. Each Series A Preferred Share is convertible into that number of Common Shares equal to the preference amount (initially $1,000) plus any accrued dividends with respect to such share, divided by the conversion price (initially $1.20), subject to adjustment as set forth in the Certificate of Designation. The Series A Preferred Shares earn a cumulative dividend of 8% per annum.